We found that the sorafenib-induced level of ferroptosis was lower in sorafenib-resistant cells with high expression of FNDC5 than in sorafenib-sensitive HCC cells, whereas the level of ferroptosis was elevated in FNDC5-knockdown sorafenib-resistant cells. Here, FNDC5 is linked to hepatocellular carcinoma.